$427 Million is the total value of SECTOR GAMMA AS's 33 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 32.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Sell | LILLY ELI & CO | $49,944,000 | -12.3% | 770,147 | -15.9% | 11.68% | -13.3% |
| BAX | Sell | BAXTER INTL INC | $36,732,000 | -6.2% | 511,800 | -5.5% | 8.59% | -7.3% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $30,087,000 | -6.4% | 2,547,600 | +1.2% | 7.04% | -7.4% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $24,240,000 | -6.0% | 237,300 | -21.0% | 5.67% | -7.0% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $18,307,000 | +4.4% | 340,600 | +1.8% | 4.28% | +3.2% |
| PKI | Buy | PERKINELMER INC | $17,329,000 | -6.4% | 397,460 | +0.5% | 4.05% | -7.5% |
| SYK | New | STRYKER CORP | $16,972,000 | – | 210,183 | +100.0% | 3.97% | – |
| DGX | Sell | QUEST DIAGNOSTICS INC | $16,937,000 | +1.9% | 279,128 | -1.4% | 3.96% | +0.8% |
| THOR | Buy | THORATEC CORP | $16,794,000 | -13.7% | 628,300 | +12.5% | 3.93% | -14.7% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $16,224,000 | +204.0% | 317,000 | +188.2% | 3.80% | +200.8% |
| CAH | Sell | CARDINAL HEALTH INC | $14,984,000 | +5.6% | 200,000 | -3.4% | 3.51% | +4.4% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $14,747,000 | -17.0% | 1,138,291 | -1.7% | 3.45% | -17.9% |
| LPNT | LIFEPOINT HOSPITALS INC | $13,817,000 | +11.4% | 199,700 | 0.0% | 3.23% | +10.2% | |
| THC | Sell | TENET HEALTHCARE CORP | $13,630,000 | +4.4% | 229,500 | -17.5% | 3.19% | +3.2% |
| CBST | Buy | CUBIST PHARMACEUTICALS INC | $13,267,000 | -1.3% | 199,990 | +3.9% | 3.10% | -2.4% |
| RMD | Sell | RESMED INC | $11,396,000 | -9.7% | 231,300 | -7.2% | 2.67% | -10.7% |
| PDCO | PATTERSON COMPANIES INC | $10,708,000 | +4.9% | 258,465 | 0.0% | 2.50% | +3.7% | |
| WCG | New | WELLCARE HEALTH PLANS INC | $10,448,000 | – | 173,145 | +100.0% | 2.44% | – |
| HSP | Sell | HOSPIRA INC | $10,406,000 | -13.4% | 200,000 | -14.5% | 2.44% | -14.3% |
| BIO | Buy | BIO RAD LABS INCcl a | $8,743,000 | +10.2% | 77,100 | +16.3% | 2.04% | +8.9% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $8,363,000 | – | 74,463 | +100.0% | 1.96% | – |
| ABC | Sell | AMERISOURCEBERGEN CORP | $7,575,000 | +4.3% | 98,000 | -2.0% | 1.77% | +3.1% |
| CYH | New | COMMUNITY HEALTH SYS INC | $6,082,000 | – | 111,000 | +100.0% | 1.42% | – |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $5,983,000 | -52.6% | 176,600 | -52.9% | 1.40% | -53.1% |
| 5100PS | New | VOLCANO CORPORATION | $5,926,000 | – | 557,000 | +100.0% | 1.39% | – |
| IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $5,668,000 | +14.6% | 114,191 | +8.6% | 1.33% | +13.3% |
| CTRX | CATAMARAN CORP | $4,784,000 | -4.5% | 113,500 | 0.0% | 1.12% | -5.6% | |
| CI | Buy | CIGNA CORPORATION | $4,444,000 | +20.8% | 49,000 | +22.5% | 1.04% | +19.5% |
| AGN | New | ALLERGAN INC | $3,564,000 | – | 20,000 | +100.0% | 0.83% | – |
| MDCO | Sell | MEDICINES CO | $3,470,000 | -35.2% | 155,450 | -15.6% | 0.81% | -35.9% |
| AVNR | Sell | AVANIR PHARMACEUTICALS INCcl a new | $2,734,000 | -27.6% | 229,400 | -65.7% | 0.64% | -28.3% |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INC | $2,565,000 | -26.6% | 85,920 | -50.7% | 0.60% | -27.4% |
| SPPI | Buy | SPECTRUM PHARMACEUTICALS INC | $566,000 | +39.1% | 69,500 | +39.0% | 0.13% | +37.5% |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -27,000 | -100.0% | -0.52% | – |
| RDY | Exit | DR REDDYS LABS LTDadr | $0 | – | -146,152 | -100.0% | -1.49% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -167,200 | -100.0% | -2.27% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -228,500 | -100.0% | -3.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.